News & Press Releases

GeneSight Mental Health Monitor: Special Election Series Update

September 17, 2024

Americans’ anxiety toward upcoming Presidential election has increased; mental health expert encourages treatment for those who are impacted Phase II of GeneSight® Mental Health Monitor Election Survey from Myriad Genetics…

Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election

June 25, 2024

Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election New Findings from Myriad Genetics Reveal One-Third of Americans Say Election Season Affects Their Mental Health …

Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor

April 17, 2024

80% of people diagnosed with anxiety, depression report losing years or decades of time SALT LAKE CITY, April 17, 2024 – An astonishing 44% of Americans feel they have lost…

Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing

April 9, 2024

Fewer patients were prescribed medications with gene-drug interactions after taking the GeneSight test SALT LAKE CITY, April 9, 2024 – Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing…

Myriad Genetics Announces Enhancements to the GeneSight^® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status

August 7, 2023

SALT LAKE CITY, Aug. 7 2023 – Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, announced enhancements to the GeneSight® Psychotropic test, a pharmacogenomic test for…

Nearly Half of BIPOC Individuals Say They Are Dissatisfied with Their Mental Health, according to Myriad Genetics Nationwide Survey

July 14, 2023

BIPOC respondents were less likely to seek help than the general population SALT LAKE CITY, July 14, 2023 – Nearly half (47%) of BIPOC (Black, Indigenous, and People of Color)…

Is “Manning Up” Bringing Men Down?

June 5, 2023

Men are less likely to have a trusted mental healthcare provider than females SALT LAKE CITY, June 5, 2023 – Only 53% of men say they have a trusted mental…

93% of Adults who Identify as LGBTQ+ Have Used Coping Mechanisms or Addictive Behaviors to Manage their Mental Health, according to Myriad Genetics Nationwide Survey

June 5, 2023

Nearly twice as many LGBTQ+ respondents say they are currently diagnosed with depression and/or anxiety than the general population SALT LAKE CITY, June 5, 2023 – Nearly all (93%) LGBTQ+…

77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey

April 19, 2023

Medication failure leads 45% of respondents with depression and/or anxiety to turn to unhealthy coping mechanisms SALT LAKE CITY, April 19, 2023 – From restricted or binge eating to excessive…

GeneSight Mental Health Monitor Reveals Gap on the Front Line of Mental Health Care

November 17, 2022

Survey finds primary care providers wish patients would raise mental health concerns so they can provide better overall care SALT LAKE CITY, Nov. 17, 2022 – More than 83% of…

IAVA and Myriad Genetics Host Live Event to Raise Awareness about Genetic Testing and Mental Health

November 10, 2022

IAVA and Myriad Genetics Host Live Event to Raise Awareness about Genetic Testing and Mental Health Clinical expert to share new research about treatment for veterans with depression New York,…

IAVA Partners with Myriad Genetics

November 7, 2022

IAVA Partners with Myriad Genetics New Technologies for Mental Health Treatments Available New York, NY, October 31, 2022 – Iraq and Afghanistan Veterans of America (IAVA), the leading voice of the…

Access to Myriad Genetics’ GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial

July 12, 2022

Access to Myriad Genetics’ GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial Study showed PGx testing helps clinicians prescribe fewer medications with gene-drug…